take deliv improv ep y/i beat
consensu y/i gain larg part driven inclus lower share
count lower tax rate although overal sale rose compstore trend remain anem
retail pharma us compstore comp rais lower end prior
guidanc rais dividend announc buy-back program
howev good news releas overshadow announc
deal acquir pillpack on-line start-up essenti ship pre-pack dose
drug share close yet news prompt market panic
view reaction similar hit grocer upon purchas
wfm pre-pack med neither uniqu difficult provid on-line rx us
grow physic pharmaci go away move service-
driven model ensur surviv doubt interest rx
fear lie fear often overdon think case
share price-to-earnings valu investor circl lower target
reflect chang sentiment current level remain so-rat
retail pharmaci usa sale y/i mainli due addit rite
aid store off-set overal comp declin given higher cost mix rite aid
store impact gm dilut bp y/i contain solid
sg y/i drive rate improv consecut quarter
bp adj oper incom y/i would grown
curtail gain prior year relat pension benefit
rx compstore sale flat y/i brand price inflat off-set reimburs
pressur impact gener script market share improv bp
record benefit strateg partnership allianc rx help
off-set part medicar part network chang
f/e compstore focu improv margin rather chase sale prove
success categori standpoint well categori continu
struggl sale cold/cough/flu product neg impact
gener mild flu season sale beauti perform well reflect strong
result beauti differenti store continu outperform non-
continu page
link scotiaview
volum close price wba-n
histor price multipl calcul use fye price valu us unless otherwis indic
ac certif import disclosur see appendix report analyst employ non-u affili
registered/qualifi research analyst finra
retail pharmaci sale y/i ex-fx rx compstore boot uk
lead declin due lower script volum decreas govern fund f/e compstore
also impact tough retail environ uk adj oper incom ex-fx mainli
due time sg rate higher bp y/i slight gross margin contract
pharmaceut wholesal sale y/i ex-fx growth emerg market
uk off-set difficult market condit continent europ adj oper incom
ex-fx higher equiti earn ex- profit decreas gener procur
pressur overhead/wag inflat
us pharmaci pharmaci usa compstore pharmaci usa compstore pharmaci gross profit sg earn oper pharmaci pharmaci interest earn earn equiti net incom non-control net incom attribut common share o/ ratesadj gross bpadj sg expens bpadj ebitda bpadj oper bpeffect incom tax
exhibit valuat multipl re-rat due challeng industri backdrop threat competit
first global pharmacy-l health well-being enterpris compani creat decemb
combin walgreen allianc boot consist three main divis retail pharmaci usa divis
consist walgreen duan read brand oper drugstor presenc state district
columbia puerto rico virgin island retail pharmaci intern divis oper drugstor
eight countri includ boot brand pharmaceut wholesal divis mainli oper allianc
healthcar brand suppli medicin healthcar product relat servic pharmaci doctor
health center hospit year distribut center countri primarili europ
portfolio product brand includ botan liz earl soap glori
reduct reimburs level private/government agenc plan third parti chang industri price
benchmark prescript drug gener drug inflat inabl success time complet pend acquisit
failur achiev synergi target regard allianc boot acquisit oper financi regulatori
difficulti could interrupt wholesal suppli drug elev debt level could reduc financi flexibl
unfavour fluctuat foreign currenc
risk acquisit integr synergi captur execut restructur program chang drug reimburs
total return index wba-n
